Showing results (231-240 of 354) with videos related to
Sort By:
Pageof 36
Transplantation Proceedings|December 17, 2009
Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case reportZ Kaposztas, B D Kahan, S M Katz, et al.Pediatric Nephrology (Berlin, Germany)|November 30, 2000
Reduced variability of neoral pharmacokinetic studies in pediatric renal transplantationH U Meier-Kriesche, R Swinford, B D Kahan, et al.Transplantation|September 1, 1983
The effect of cyclosporine on early graft function in human renal transplantationS M Flechner, W D Payne, C Van Buren, et al.Immunological Communications|January 1, 1982
A new approach for the immunogenic presentation of membrane-bound human colon tumor antigensB H Tom, T J Goodwin, J Sengupta, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 14, 2001
Sirolimus improves the two-year outcome of renal allografts in African-American patientsH Podder, J Podbielski, I Hussein, et al.Clinical Biochemistry|October 1, 1996
Radioreceptor assay for sirolimusN Goodyear, K L Napoli, J N Murthy, et al.Cancer Research|May 1, 1980
Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174TL P Rutzky, C I Kaye, M J Siciliano, et al.The Journal of Surgical Research|May 1, 1987
The protective effect of hepatic dysfunction on vascularized allograft survivalP T Roughneen, R Didlake, S C Kumar, et al.Therapeutic Drug Monitoring|August 26, 1998
A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantationH U Meier-Kriesche, B Kaplan, P Brannan, et al.Cancer|November 1, 1977
Active specific immunotherapy potential for the treatment of large bowel cancerB D Kahan, N R Pellis, L P Rutzky, et al.Pageof 36